1216.11.003 Boehringer Ingelheim Investigational Site
Chicago, Illinois
0 studies enrolling now ยท 1 studies all time
What they study most
Carcinoma, Small Cell
Studies at this site
- BI 2536 Second Line Monotherapy in SCLC โ Completed
Chicago, Illinois
0 studies enrolling now ยท 1 studies all time
Carcinoma, Small Cell